Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain

Published:2021-01-01 Issue:1 Volume:24 Page:628-636
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Carcedo Rodriguez David¹^ORCID,Artola Urain Teresa²,Chinea Rodriguez Anabelle³,García Torres Estefanía⁴,González Vicent Marta⁵,Gutiérrez García Gonzalo⁶^ORCID,Regueiro García Alexandra⁷,Calvo Hidalgo Marcos⁸,Villacampa Alba¹

Affiliation:

1. Hygeia Consulting, S.L, Madrid, Spain

2. Hematology and Hemotherapy Department, Hospital Donostia, País Vasco, Spain

3. Hematology and Hemotherapy Services, Hospital Ramón y Cajal, Madrid, Spain

4. Hematology Department, Hospital Reina Sofía, Córdoba, Spain

5. Hematology and Hemotherapy Services, Hospital Niño Jesús, Madrid, Spain

6. Bone Marrow Transplant Unit – Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain

7. Pediatrics Department, C.H.U. de Santiago, Galicia, Spain

8. Onco-Hematology, Jazz Pharmaceuticals, Iberia, Spain

Funder

Jazz Pharmaceuticals

Publisher